Who has invested in ApiJect?

Royalty Pharma, Jefferies Financial Group are named among the investors backing ApiJect.

ApiJect Funding: $200M Raised, Series C (2022)

ApiJect funding overview

ApiJect is based in Stamford, Connecticut. ApiJect has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for ApiJect runs through 2022; nothing later has been disclosed. Investors on record include Royalty Pharma, Jefferies Financial Group. 2 distinct backers are named across the disclosed rounds.

ApiJect at a glance

Total raised: $200M
Latest round: Series C
Latest round date: January 2022
Headquarters: Stamford, Connecticut
Notable investors: Royalty Pharma, Jefferies Financial Group

Frequently asked about ApiJect funding

How much has ApiJect raised?: ApiJect has raised $200M in total disclosed funding across the rounds on record.
Who has invested in ApiJect?: Royalty Pharma, Jefferies Financial Group are named among the investors backing ApiJect.
What was the latest ApiJect funding round?: The most recent disclosed round is a Series C, announced in January 2022.
Where is ApiJect based?: ApiJect is based in Stamford, Connecticut.
When did ApiJect last raise?: The last disclosed ApiJect round closed in January 2022 at Series C.

Round data for ApiJect is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Stamford and backer lists below.

ApiJect Funding: $200M Raised, Series C (2022)

ApiJect funding overview

ApiJect at a glance

Frequently asked about ApiJect funding

Companies related to ApiJect (39)

Browse related funding lists (3)